Minerva Neurosciences, Inc.
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
NERV | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6033802058
- LEI:
- Country:
- United States of America
- Address:
- 1500 DISTRICT AVENUE, 1803 BURLINGTON
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system (CNS) diseases. The company's core expertise lies in clinical development, with an emphasis on designing innovative trials with clinical endpoints directly related to patient benefit. Its programs target a range of unmet needs within CNS, including treatments for the negative symptoms of schizophrenia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Minerva Neurosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Minerva Neurosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Minerva Neurosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
